id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-V-1257-0003,FDA,FDA-2021-V-1257,Variance Approval Letter from FDA CDRH to Nick Glover,Other,Approval for Variance (VRA),2021-12-29T05:00:00Z,2021,12,2021-12-29T05:00:00Z,,2021-12-29T20:54:12Z,,0,0,0900006484f009a5
FDA-2021-V-1257-0001,FDA,FDA-2021-V-1257,Variance Application from Nick Glover,Other,Application for Variance (VAR),2021-11-29T05:00:00Z,2021,11,2021-11-29T05:00:00Z,,2021-11-29T16:24:18Z,,0,0,0900006484e868ef
FDA-2021-V-1257-0002,FDA,FDA-2021-V-1257,Acknowledgment Letter from FDA DMS to Nick Glover,Other,Acknowledgement Letter/Receipt,2021-11-29T05:00:00Z,2021,11,2021-11-29T05:00:00Z,,2021-11-29T16:24:24Z,,0,0,0900006484e86dd4